149 related articles for article (PubMed ID: 19591879)
1. Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.
Werk D; Pinkert S; Heim A; Zeichhardt H; Grunert HP; Poller W; Erdmann VA; Fechner H; Kurreck J
Antiviral Res; 2009 Sep; 83(3):298-306. PubMed ID: 19591879
[TBL] [Abstract][Full Text] [Related]
2. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
3. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
4. Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3.
Dutkiewicz M; Grunert HP; Zeichhardt H; Lena SW; Wengel J; Kurreck J
FEBS Lett; 2008 Sep; 582(20):3061-6. PubMed ID: 18691577
[TBL] [Abstract][Full Text] [Related]
5. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity.
Zhang K; Yu H; Xie W; Xu Z; Zhou S; Huang C; Sheng H; He X; Xiong J; Qian G
J Biotechnol; 2013 Apr; 164(4):461-8. PubMed ID: 23376619
[TBL] [Abstract][Full Text] [Related]
6. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
[TBL] [Abstract][Full Text] [Related]
7. Development of potential antiviral strategy against coxsackievirus B4.
Tan EL; Wong AP; Poh CL
Virus Res; 2010 Jun; 150(1-2):85-92. PubMed ID: 20214933
[TBL] [Abstract][Full Text] [Related]
8. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand.
Yuan J; Cheung PK; Zhang HM; Chau D; Yang D
J Virol; 2005 Feb; 79(4):2151-9. PubMed ID: 15681418
[TBL] [Abstract][Full Text] [Related]
10. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice.
Kim JY; Chung SK; Hwang HY; Kim H; Kim JH; Nam JH; Park SI
Virus Res; 2007 Apr; 125(1):9-13. PubMed ID: 17222937
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
[TBL] [Abstract][Full Text] [Related]
12. Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir.
Pozzuto T; Röger C; Kurreck J; Fechner H
Antiviral Res; 2015 Aug; 120():72-8. PubMed ID: 26026665
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of highly potent siRNAs against echovirus 30 and its receptor.
Rothe D; Werk D; Niedrig S; Horbelt D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Virol Methods; 2009 May; 157(2):211-8. PubMed ID: 19187792
[TBL] [Abstract][Full Text] [Related]
14. [Antisense oligonucleotide inhibition of coxsackievirus B3 gene expression in HeLa cells and dose-response experiments].
Liu ZW; Sun HM; Xiao ZH; Qiu N; Zhang T; Zhao JM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):62-5. PubMed ID: 15340530
[TBL] [Abstract][Full Text] [Related]
15. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
16. Application of small interfering RNAs modified by unlocked nucleic acid (UNA) to inhibit the heart-pathogenic coxsackievirus B3.
Werk D; Wengel J; Wengel SL; Grunert HP; Zeichhardt H; Kurreck J
FEBS Lett; 2010 Feb; 584(3):591-8. PubMed ID: 20005874
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
18. A small interfering RNA targeting coxsackievirus B3 protects permissive HeLa cells from viral challenge.
Ahn J; Jun ES; Lee HS; Yoon SY; Kim D; Joo CH; Kim YK; Lee H
J Virol; 2005 Jul; 79(13):8620-4. PubMed ID: 15956603
[TBL] [Abstract][Full Text] [Related]
19. Strand-specific silencing of a picornavirus by RNA interference: evidence for the superiority of plus-strand specific siRNAs.
Schubert S; Rothe D; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Antiviral Res; 2007 Mar; 73(3):197-205. PubMed ID: 17112603
[TBL] [Abstract][Full Text] [Related]
20. Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24.
Jun EJ; Nam YR; Ahn J; Tchah H; Joo CH; Jee Y; Kim YK; Lee H
Biochem Biophys Res Commun; 2008 Nov; 376(2):389-94. PubMed ID: 18793610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
